Forvis Mazars Wealth Advisors LLC grew its stake in MetLife, Inc. (NYSE:MET – Free Report) by 1.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,679 shares of the financial services provider’s stock after buying an additional 343 shares during the period. Forvis Mazars Wealth Advisors LLC’s holdings in MetLife were worth $1,857,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. MeadowBrook Investment Advisors LLC boosted its holdings in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. boosted its stake in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife during the third quarter worth $30,000. Retirement Wealth Solutions LLC bought a new position in MetLife during the fourth quarter worth $32,000. Finally, Sierra Ocean LLC acquired a new position in MetLife in the fourth quarter valued at $32,000. 94.99% of the stock is currently owned by institutional investors.
MetLife Trading Down 2.1 %
NYSE:MET opened at $81.02 on Monday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05. The company has a market cap of $56.10 billion, a PE ratio of 13.57, a PEG ratio of 0.65 and a beta of 1.07. The firm has a 50-day moving average of $83.41 and a 200-day moving average of $81.53.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.69%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio (DPR) is presently 36.52%.
Analysts Set New Price Targets
Several research firms have recently weighed in on MET. Keefe, Bruyette & Woods lowered their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a research report on Wednesday, February 12th. Wells Fargo & Company lifted their target price on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a report on Wednesday, February 19th. Barclays cut their price target on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. TD Cowen lifted their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Finally, JPMorgan Chase & Co. increased their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $92.58.
View Our Latest Research Report on MET
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Investing in Commodities: What Are They? How to Invest in Them
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- What is a SEC Filing?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What Investors Need to Know to Beat the Market
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.